Corporate Health Screening: Blood Testing for Employees
Sickness absence in the UK has reached its highest level in over a decade. According to CIPD research, employees now take an average of 9.4 days off sick per year — up from 5.8 days pre-pandemic. For a company of 100 people, that is 940 lost working days every year. The cost is staggering: absenteeism alone costs UK employers between £429 and £702 per employee annually, before you factor in presenteeism, recruitment, and the quiet erosion of team morale that chronic illness creates.
Most of this is preventable. Not all of it — but a meaningful share. The conditions that drive long-term sickness absence — cardiovascular disease, type 2 diabetes, thyroid dysfunction, chronic fatigue linked to nutritional deficiencies — are conditions that blood testing can detect months or years before symptoms become disabling. Corporate health screening is how forward-thinking employers are catching these problems early, reducing absence, and demonstrating a genuine duty of care that goes beyond a fruit bowl in the kitchen.
The UK corporate wellness market is now valued at over £2.8 billion and growing at nearly 5% per year. Blood testing is one of its fastest-growing segments — and for good reason. This guide explains what corporate blood testing involves, the evidence behind it, how at-home testing works for distributed teams, and what employers need to know about cost, privacy, and implementation.
Key Takeaways
- UK sickness absence has surged to 9.4 days per employee per year — costing employers up to £702 per head annually. Corporate blood testing catches the underlying health issues before they become absences.
- Workplace health programmes return £4.70 for every £1 invested according to Deloitte analysis, through reduced absenteeism, lower presenteeism, and improved retention.
- A comprehensive corporate blood test covers 45–70 biomarkers — including cholesterol, diabetes markers, thyroid function, liver and kidney health, vitamins, iron, hormones, and inflammation — far beyond what a standard NHS Health Check includes.
- At-home venous blood testing eliminates logistical barriers — employees receive professional nurse-led phlebotomy at home or in the office, with results delivered via a secure online dashboard. No clinic visits, no time off work.
- Health data is special category data under UK GDPR — employers never see individual results. A well-structured programme gives employees direct, private access to their own data while providing employers with anonymised, aggregate insights only.
Why Blood Testing for Employees?
Annual health screenings at most UK companies — if they exist at all — involve a questionnaire, a BMI check, and perhaps a blood pressure reading. Blood testing goes deeper. A single venous draw can assess cardiovascular risk, metabolic health, organ function, nutritional status, hormonal balance, and systemic inflammation — all from one sample.
The business case is straightforward. Ill health costs the UK economy £150 billion annually. Presenteeism — employees at their desks but working at reduced capacity — costs UK businesses £24–28 billion per year. These costs are not driven by rare diseases. They are driven by high cholesterol, pre-diabetes, low iron, vitamin D deficiency, and underactive thyroids. All detectable. All actionable. All through blood testing.
There is also the retention angle. A RAND Europe study found that companies investing in employee wellbeing report improved morale, stronger cultures, and better staff retention. Comprehensive blood testing signals genuine commitment to your people’s health.
What Corporate Health Screening Includes
A basic corporate health check might cover blood pressure, BMI, and a cholesterol spot-check. A comprehensive blood test goes significantly further. Here is what a thorough corporate screening panel typically includes:
| Category | Biomarkers Tested | Why It Matters at Work |
|---|---|---|
| Heart & Lipids | Total cholesterol, HDL, LDL, triglycerides, Non-HDL, ApoB | Cardiovascular disease is the UK's leading cause of death. Over 50% of adults have cholesterol above guidelines — most are unaware. |
| Diabetes & Metabolism | HbA1c, fasting glucose | 4.3 million people in the UK have diabetes, and an estimated 850,000 are undiagnosed. Pre-diabetes is reversible if caught early. |
| Thyroid Function | TSH, Free T4, Free T3 | Underactive thyroid causes fatigue, weight gain, and brain fog — directly impacting productivity. Affects 5–10% of the UK population. |
| Liver Health | ALT, AST, GGT, ALP, bilirubin, albumin | Non-alcoholic fatty liver disease affects 25% of UK adults. Entirely asymptomatic until advanced. Liver enzymes are the earliest warning. |
| Kidney Function | Creatinine, eGFR, urea, uric acid | Chronic kidney disease is often silent for years. Early detection prevents progression and reduces long-term healthcare costs. |
| Vitamins & Minerals | Vitamin D, B12, folate, magnesium | 1 in 5 UK adults are vitamin D deficient. B12 deficiency causes fatigue and cognitive issues. Both are simple to correct once identified. |
| Iron Studies | Ferritin, serum iron, TIBC, transferrin saturation | Iron deficiency is the most common nutritional deficiency worldwide and a leading cause of workplace fatigue, particularly in women. |
| Hormones | Testosterone, oestradiol, FSH, SHBG, DHEA-S, cortisol | Hormonal imbalances affect energy, mood, sleep, and cognitive function. Perimenopause symptoms start in the early 40s for many women. |
| Inflammation | hs-CRP, ESR | Chronic inflammation is linked to cardiovascular disease, autoimmune conditions, and long-term sickness. CRP is a powerful early warning marker. |
| Full Blood Count | Red cells, white cells, platelets, haemoglobin | Screens for anaemia, infection, and blood disorders. Provides a baseline for overall health assessment. |
The difference between a basic health check and a comprehensive blood panel is the difference between checking the oil light and running full engine diagnostics. Only one catches the problems that have not yet triggered a warning.
Benefits for Employers
The evidence base for workplace health screening is substantial. Here are the key benefits with supporting data:
| Benefit | Evidence / Statistics |
|---|---|
| Reduced absenteeism | Organisations prioritising employee health report absenteeism reductions of over 25%. With average absence costing £547–£702 per employee per year, even a 25% reduction across 200 staff saves £27,000–£35,000 annually. |
| Lower presenteeism | Presenteeism costs UK businesses £24–28 billion per year — more than absenteeism. Blood testing identifies conditions like thyroid dysfunction, iron deficiency, and vitamin D deficiency that reduce cognitive function and energy while employees remain at their desks. |
| Strong financial ROI | Deloitte’s analysis of 26 studies found employers receive £4.70 for every £1 invested in health and wellbeing. Public Health England found returns ranging from £11 to £99 per £1 for broader societal impact. |
| Improved retention | Health benefits are now a top-three factor in employee retention decisions. Companies offering comprehensive health screening report lower voluntary turnover and reduced recruitment costs — which average £6,000–£30,000 per hire depending on seniority. |
| Duty of care compliance | Under the Health and Safety at Work Act 1974, employers have a duty to ensure the health of employees so far as is reasonably practicable. Proactive health screening demonstrates compliance and reduces liability exposure. |
| Data-driven wellbeing strategy | Anonymised aggregate blood test data reveals workforce-wide patterns — for example, if 40% of staff are vitamin D deficient, a simple supplementation programme becomes a targeted intervention rather than a generic perk. |
| SSP cost mitigation | From April 2026, Statutory Sick Pay will be payable from day one of illness (the three waiting days are being abolished). This increases the direct cost of every absence — making prevention through early detection even more financially compelling. |
The maths in context: A company of 150 employees spending £100 per person on annual blood testing invests £15,000. If that programme prevents just 5 long-term absences (average UK cost per long-term absence: £4,000–£8,000) and reduces short-term absence by 20%, the return comfortably exceeds 3:1 — before accounting for presenteeism savings, retention improvements, and reduced employer liability insurance premiums.
Benefits for Employees
Corporate health screening is not just an employer benefit — it is a personal health opportunity that most employees would never arrange for themselves. Here is what it means for the individual:
- Early detection of silent conditions: High cholesterol, pre-diabetes, thyroid dysfunction, and iron deficiency rarely produce obvious symptoms until well established. A blood test catches them before they become a medical problem or a barrier to performance.
- Personalised health baseline: Most employees have never had a comprehensive blood test. The first corporate screening creates a personal baseline that makes future changes far easier to interpret. Trend data is more powerful than any single snapshot.
- Actionable results, not just data: Results come with clear explanations, flagged abnormalities, GP referral guidance, and practical lifestyle recommendations tailored to individual findings.
- Convenience: At-home or on-site testing eliminates the need to take time off work or navigate NHS referral pathways. The entire process happens without disrupting the working day.
- Privacy and control: The employer never sees individual results. Employees receive their data directly and decide what to act on. The power stays with the individual.
- Access to tests the NHS does not offer: The NHS Health Check covers 3–4 markers every five years. Corporate blood testing covers 45–70 biomarkers annually — tests that would otherwise require a private consultation costing £300 or more.
How At-Home Corporate Testing Works
The biggest barrier to corporate health screening has traditionally been logistics — booking clinic appointments, coordinating schedules, and excluding remote teams. At-home blood testing solves this. Here is how it works with Lola Health:
Option 1: Nurse-Led On-Site or At-Home Phlebotomy
- The employer selects a testing panel — typically Core Health 45 (45 biomarkers) or Peak Insights 70 (70 biomarkers) depending on the depth of screening required.
- Lola arranges professional phlebotomists to visit the workplace on a scheduled day, or to visit each employee at home. This uses the same qualified nurses who perform NHS and private blood draws — a professional venous blood draw, not a finger-prick.
- Samples are sent to a UKAS-accredited laboratory (the same labs used by the NHS) for analysis. Results are typically available within 2–4 working days.
- Each employee receives their results privately via a secure online dashboard with clear explanations, reference ranges, flagged abnormalities, and GP referral guidance where needed.
- The employer receives an anonymised aggregate report — workforce-level trends only (e.g., “38% of participants showed sub-optimal vitamin D levels”), enabling targeted wellbeing initiatives without compromising individual privacy.
Option 2: Home Test Kits (for Distributed Teams)
- Test kits are shipped directly to each employee’s home address. Each kit contains everything needed for the blood draw, including pre-paid return packaging.
- A qualified phlebotomist visits the employee at home at a booked appointment time. The blood draw takes approximately 10 minutes.
- The phlebotomist handles sample packaging and return shipping — the employee does nothing beyond sitting for the draw.
- Results are delivered to the individual within 2–4 working days via the same secure platform, with the same clinical-grade analysis and explanations.
Both options use venous blood draws (from the arm), not finger-prick capillary samples. Venous samples provide enough volume to test 45–70 biomarkers with laboratory-grade accuracy. Finger-prick tests are limited to a handful of markers and carry a higher risk of sample failure.
Uptake tip: Companies that offer testing during working hours and communicate the programme as a benefit (not an obligation) consistently see the highest participation rates — typically 60–80%. Framing matters: “We’re giving you access to a comprehensive health check” performs better than “We want to test your blood.”
Cost Considerations
Corporate blood testing costs depend on the number of employees, the depth of the panel, and whether testing is delivered on-site or at home. Here is a realistic guide:
- Core Health 45 (45 biomarkers): Covers the essentials — cholesterol, diabetes, thyroid, liver, kidney, iron, vitamins, and inflammation. This is the most popular corporate option and provides a thorough annual health baseline. View the full panel.
- Peak Insights 70 (70 biomarkers): Adds hormones, advanced cardiovascular markers (ApoB, Lp(a)), and additional metabolic markers. Best suited for leadership teams, high-performance environments, or companies wanting the most comprehensive screening available. View the full panel.
- Volume discounts: Per-test costs decrease with larger team sizes. Lola Health offers tiered corporate pricing — contact us for a quote tailored to your headcount and testing requirements.
- Frequency: Annual testing is the standard for corporate programmes. Some companies opt for biannual testing for senior leaders or employees in high-stress roles. Annual testing creates the trend data that makes results genuinely actionable.
The relevant comparison is not “blood test versus no blood test” — it is testing cost versus the cost of undetected health problems. A single long-term absence costs £4,000–£8,000. A single resignation costs £6,000–£30,000 in recruitment. The economics favour prevention overwhelmingly.
GDPR and Privacy
Health data is classified as “special category data” under UK GDPR — subject to the highest level of protection. Employers running corporate health screening need to get this right. Here is how a compliant programme works:
- Individual results are never shared with the employer. Each employee receives results directly via a private, secure dashboard. The employer has no access to individual-level data.
- Participation must be voluntary. Consent for health data processing must be freely given — employees must be able to decline without penalty.
- Aggregate reporting only. The employer receives anonymised workforce-level summaries (e.g., “35% of participants had vitamin D below optimal range”). For very small teams, aggregate reporting may need to be suppressed to prevent identification by elimination.
- Data minimisation applies. Results are processed by the testing provider and accredited laboratory — not stored on the employer’s systems.
- Formal data processing agreement. The employer should have a DPA with the testing provider specifying lawful basis, retention periods, security measures, and employee rights.
- Employees retain full control. Individuals have the right to access, correct, and request deletion of their health data, and to withdraw consent at any time.
Important note: The ICO’s guidance on workers’ health information is currently under review following the Data (Use and Access) Act 2025. The core principles of consent, minimisation, and security remain unchanged, but employers should monitor for updated guidance. Lola Health’s corporate programme is designed to be fully GDPR-compliant by default — the architecture ensures employers never access individual results.
Getting Started with Corporate Blood Testing
Implementing a corporate health screening programme does not require a dedicated wellbeing team. Here is a practical roadmap:
- Define the scope: Decide who is eligible and the testing depth — Core Health 45 for broad screening or Peak Insights 70 for comprehensive analysis.
- Communicate the benefit: Frame it as a perk, not an obligation. Emphasise privacy, convenience, and that this is a benefit worth £100+ provided at no cost to the employee.
- Choose delivery format: On-site nurse visits for office-based teams, at-home phlebotomy for distributed workforces. Lola Health supports both.
- Schedule and book: Lola coordinates directly with employees to book appointments at times that suit them.
- Results and follow-up: Employees receive results within 2–4 working days. The employer receives an anonymised aggregate report within 2 weeks.
- Repeat annually: Year-on-year data reveals trends, validates wellbeing initiatives, and gives employees a longitudinal view of their own health.
Ready to Introduce Blood Testing for Your Team?
Lola Health provides corporate blood testing programmes for UK businesses of all sizes. From 10 employees to 1,000+, we handle everything — from nurse-led phlebotomy to UKAS-accredited lab analysis and secure individual results delivery.
Core Health 45 — 45 Biomarkers Peak Insights 70 — 70 Biomarkers
For corporate enquiries, volume pricing, and bespoke programme design, contact us at [email protected]
Comprehensive Blood Testing for Your Team
Corporate health screening that includes blood testing catches conditions like pre-diabetes, thyroid dysfunction, iron deficiency, and cardiovascular risk factors before they impact productivity and absence. A comprehensive panel with at-home phlebotomy visits means zero disruption to the working day.
All results reviewed by a doctor. Free delivery. Results in 2-3 working days.
Frequently Asked Questions
What is corporate health screening?
Corporate health screening is a workplace programme where employers provide employees with health assessments — typically including blood testing — to detect health risks early and reduce sickness absence. Modern corporate blood testing covers 45–70 biomarkers including cholesterol, diabetes markers, thyroid function, liver and kidney health, vitamins, iron, hormones, and inflammation.
Can my employer see my blood test results?
No. Individual results are delivered directly and privately to each employee. Health data is special category data under UK GDPR, and Lola Health’s corporate programme ensures employers only receive anonymised, aggregate workforce reports — never individual results.
How many biomarkers should a corporate blood test include?
At least 40–45 biomarkers for a comprehensive baseline: cardiovascular markers, HbA1c, thyroid, liver, kidney, iron, vitamins (D, B12, folate), and inflammation. A 70-biomarker panel adds hormones and advanced lipids (ApoB, Lp(a)). Core Health 45 and Peak Insights 70 are the two most common corporate options.
How does at-home blood testing work for corporate programmes?
A qualified phlebotomist visits each employee at the workplace or at home. The venous blood draw takes approximately 10 minutes. Samples go to a UKAS-accredited laboratory, and results are available within 2–4 working days via a secure online dashboard. Zero time off work required.
What is the ROI of corporate health screening?
Deloitte’s analysis of 26 studies found employers receive £4.70 for every £1 invested, through reduced absenteeism (over 25% reduction), lower presenteeism, improved retention, and reduced insurance premiums. Public Health England found broader returns of £11 to £99 per £1 invested.
Is corporate health screening a legal requirement?
Not in general, though employers have a duty of care under the Health and Safety at Work Act 1974. Certain industries require specific occupational health screenings, but comprehensive blood testing is a voluntary benefit. Participation must also be voluntary under UK GDPR.
At-Home Blood Testing
Check your levels from home
Professional phlebotomist visit. Doctor-reviewed results in 2-5 days. Track your health with comprehensive blood panels.
→45-70 biomarkers tested · Venous blood draw · From £130